Detalhe da pesquisa
1.
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis.
Clin Infect Dis
; 56(11): 1646-53, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23429381
2.
Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.
Hepatology
; 56(4): 1261-70, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22508322
3.
Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Clin Infect Dis
; 55(12): 1719-26, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-22955435
4.
[Measurement of hepatitis C virus RNA 12 weeks after treatment predicts sustained virological response in HIV-HCV co-infected patients]. / La valoración de RNA del virus de la hepatitis C realizada a las 12 semanas de finalizar el tratamiento predice la respuesta virológica sostenida en enfermos con coinfección por VIH y VHC.
Enferm Infecc Microbiol Clin
; 30(1): 15-7, 2012 Jan.
Artigo
Espanhol
| MEDLINE | ID: mdl-21908078
5.
Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation.
Liver Int
; 31(6): 850-8, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21645216
6.
Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
Clin Infect Dis
; 49(8): 1274-82, 2009 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19772387
7.
Antiretroviral therapy partially improves the abnormalities of dendritic cells and lymphoid and myeloid regulatory populations in recently infected HIV patients.
Sci Rep
; 9(1): 11654, 2019 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31406185
8.
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.
J Antimicrob Chemother
; 62(4): 793-6, 2008 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-18567911
9.
Natural history of compensated and decompensated HCV-related cirrhosis in HIV-infected patients: a prospective multicentre study.
Antivir Ther
; 12(6): 899-907, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17926644
10.
Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients.
Antivir Ther
; 12(4): 523-9, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17668561
11.
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients.
Antivir Ther
; 12(8): 1225-35, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-18240862
12.
Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.
AIDS
; 20(1): 49-57, 2006 Jan 02.
Artigo
Inglês
| MEDLINE | ID: mdl-16327319
13.
Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
Antivir Ther
; 11(7): 839-46, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-17302246
14.
Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
AIDS Res Hum Retroviruses
; 22(12): 1236-41, 2006 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17209765
15.
Dilutional hyponatremia in patients with cirrhosis and ascites.
Arch Intern Med
; 162(3): 323-8, 2002 Feb 11.
Artigo
Inglês
| MEDLINE | ID: mdl-11822925
16.
Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
Clin Infect Dis
; 36(4): 491-8, 2003 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12567308
17.
Clinical and virological efficacy of etravirine plus two active Nucleos(t)ide analogs in an heterogeneous HIV-infected population.
PLoS One
; 9(5): e97262, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24836963
18.
Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C.
AIDS Res Hum Retroviruses
; 29(2): 223-5, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22966845
19.
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients.
AIDS
; 26(13): 1721-4, 2012 Aug 24.
Artigo
Inglês
| MEDLINE | ID: mdl-22695304
20.
Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV.
Lancet Infect Dis
; 14(1): 13-14, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24355031